The list released by the National Authority for Medicines and Health Products (Infarmed), which contains 21 more drugs than in October, also includes antibiotics, medicines used to treat attention deficit hyperactivity disorder, epilepsy, opioid overdoses, and vaccines against tuberculosis and hepatitis A.

This list of medicines whose export is temporarily suspended is defined every month and includes medicines that were out of stock in the previous month and whose impact on public health was considered medium or high, as well as others that are being supplied under Exceptional Use Authorization (AUE).

The suspension of exports aims to guarantee the supply of the national market and applies to all participants in the supply chain, including manufacturers.

Infarmed monitors information on shortages and cessations of marketing daily to identify and prevent critical situations that could affect the availability of medicines.

The national medicines authority is part of the European network of contact points for national competent authorities, the European Medicines Agency (EMA), and the European Commission, which, since April 2019, has been used to share information on supply disruptions and availability issues of medicines authorized in the European Union.